Anti-platelet antibody immunoassays in childhood immune thrombocytopenia : a systematic review
© 2020 The Authors. Vox Sanguinis published by John Wiley & Sons Ltd on behalf of International Society of Blood Transfusion..
BACKGROUND: In adult immune thrombocytopenia (ITP), an acquired autoimmune bleeding disorder, anti-platelet autoantibody testing may be useful as a rule-in test. Childhood ITP has different disease characteristics, and the diagnostic and prognostic value of anti-platelet antibody testing remains uncertain.
OBJECTIVE: To systematically review the diagnostic accuracy of anti-platelet autoantibody testing in childhood ITP.
METHODS: PubMed and EMBASE were searched for studies evaluating immunoassays in childhood ITP. Study quality was assessed (QUADAS2), and evidence was synthesized descriptively.
RESULTS: In total, 40 studies (1606 patients) were identified. Nine studies reported sufficient data to determine diagnostic accuracy measures. Anti-platelet IgG antibody testing showed a moderate sensitivity (0·36-0·80 platelet-associated IgG [direct test]; 0·19-0·39 circulating IgG [indirect test]). In studies that reported control data, including patients with non-immune thrombocytopenia, specificity was very good (0·80-1·00). Glycoprotein-specific immunoassays showed comparable sensitivity (three studies) and predominantly identified IgG anti-GP IIb/IIIa antibodies, with few IgG anti-GP Ib/IX antibodies. Anti-platelet IgM antibodies were identified in a substantial proportion of children (sensitivity 0·62-0·64 for direct and indirect tests).
CONCLUSION: The diagnostic evaluation of IgG and IgM anti-platelet antibodies may be useful as a rule-in test for ITP. In children with insufficient platelets for a direct test, indirect tests may be performed instead. A negative test does not rule out the diagnosis of ITP. Future studies should evaluate the value of anti-platelet antibody tests in thrombocytopenic children with suspected ITP.
Medienart: |
E-Artikel |
---|
Erscheinungsjahr: |
2020 |
---|---|
Erschienen: |
2020 |
Enthalten in: |
Zur Gesamtaufnahme - volume:115 |
---|---|
Enthalten in: |
Vox sanguinis - 115(2020), 4 vom: 21. Mai, Seite 323-333 |
Sprache: |
Englisch |
---|
Beteiligte Personen: |
Schmidt, David E [VerfasserIn] |
---|
Links: |
---|
Anmerkungen: |
Date Completed 28.08.2020 Date Revised 29.03.2024 published: Print-Electronic Citation Status MEDLINE |
---|
doi: |
10.1111/vox.12894 |
---|
funding: |
|
---|---|
Förderinstitution / Projekttitel: |
|
PPN (Katalog-ID): |
NLM306745097 |
---|
LEADER | 01000caa a22002652 4500 | ||
---|---|---|---|
001 | NLM306745097 | ||
003 | DE-627 | ||
005 | 20240329232404.0 | ||
007 | cr uuu---uuuuu | ||
008 | 231225s2020 xx |||||o 00| ||eng c | ||
024 | 7 | |a 10.1111/vox.12894 |2 doi | |
028 | 5 | 2 | |a pubmed24n1354.xml |
035 | |a (DE-627)NLM306745097 | ||
035 | |a (NLM)32080872 | ||
040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
041 | |a eng | ||
100 | 1 | |a Schmidt, David E |e verfasserin |4 aut | |
245 | 1 | 0 | |a Anti-platelet antibody immunoassays in childhood immune thrombocytopenia |b a systematic review |
264 | 1 | |c 2020 | |
336 | |a Text |b txt |2 rdacontent | ||
337 | |a ƒaComputermedien |b c |2 rdamedia | ||
338 | |a ƒa Online-Ressource |b cr |2 rdacarrier | ||
500 | |a Date Completed 28.08.2020 | ||
500 | |a Date Revised 29.03.2024 | ||
500 | |a published: Print-Electronic | ||
500 | |a Citation Status MEDLINE | ||
520 | |a © 2020 The Authors. Vox Sanguinis published by John Wiley & Sons Ltd on behalf of International Society of Blood Transfusion. | ||
520 | |a BACKGROUND: In adult immune thrombocytopenia (ITP), an acquired autoimmune bleeding disorder, anti-platelet autoantibody testing may be useful as a rule-in test. Childhood ITP has different disease characteristics, and the diagnostic and prognostic value of anti-platelet antibody testing remains uncertain | ||
520 | |a OBJECTIVE: To systematically review the diagnostic accuracy of anti-platelet autoantibody testing in childhood ITP | ||
520 | |a METHODS: PubMed and EMBASE were searched for studies evaluating immunoassays in childhood ITP. Study quality was assessed (QUADAS2), and evidence was synthesized descriptively | ||
520 | |a RESULTS: In total, 40 studies (1606 patients) were identified. Nine studies reported sufficient data to determine diagnostic accuracy measures. Anti-platelet IgG antibody testing showed a moderate sensitivity (0·36-0·80 platelet-associated IgG [direct test]; 0·19-0·39 circulating IgG [indirect test]). In studies that reported control data, including patients with non-immune thrombocytopenia, specificity was very good (0·80-1·00). Glycoprotein-specific immunoassays showed comparable sensitivity (three studies) and predominantly identified IgG anti-GP IIb/IIIa antibodies, with few IgG anti-GP Ib/IX antibodies. Anti-platelet IgM antibodies were identified in a substantial proportion of children (sensitivity 0·62-0·64 for direct and indirect tests) | ||
520 | |a CONCLUSION: The diagnostic evaluation of IgG and IgM anti-platelet antibodies may be useful as a rule-in test for ITP. In children with insufficient platelets for a direct test, indirect tests may be performed instead. A negative test does not rule out the diagnosis of ITP. Future studies should evaluate the value of anti-platelet antibody tests in thrombocytopenic children with suspected ITP | ||
650 | 4 | |a Journal Article | |
650 | 4 | |a Systematic Review | |
650 | 4 | |a autoantibodies | |
650 | 4 | |a clinical laboratory techniques | |
650 | 4 | |a immune thrombocytopenia | |
650 | 4 | |a paediatrics | |
650 | 4 | |a systematic review | |
650 | 7 | |a Autoantibodies |2 NLM | |
650 | 7 | |a Platelet Glycoprotein GPIIb-IIIa Complex |2 NLM | |
650 | 7 | |a Platelet Glycoprotein GPIb-IX Complex |2 NLM | |
700 | 1 | |a Lakerveld, Anke J |e verfasserin |4 aut | |
700 | 1 | |a Heitink-Pollé, Katja M J |e verfasserin |4 aut | |
700 | 1 | |a Bruin, Marrie C A |e verfasserin |4 aut | |
700 | 1 | |a Vidarsson, Gestur |e verfasserin |4 aut | |
700 | 1 | |a Porcelijn, Leendert |e verfasserin |4 aut | |
700 | 1 | |a de Haas, Masja |e verfasserin |4 aut | |
773 | 0 | 8 | |i Enthalten in |t Vox sanguinis |d 1952 |g 115(2020), 4 vom: 21. Mai, Seite 323-333 |w (DE-627)NLM000095028 |x 1423-0410 |7 nnns |
773 | 1 | 8 | |g volume:115 |g year:2020 |g number:4 |g day:21 |g month:05 |g pages:323-333 |
856 | 4 | 0 | |u http://dx.doi.org/10.1111/vox.12894 |3 Volltext |
912 | |a GBV_USEFLAG_A | ||
912 | |a GBV_NLM | ||
951 | |a AR | ||
952 | |d 115 |j 2020 |e 4 |b 21 |c 05 |h 323-333 |